BIS Research ( Business Intelligence and Strategy Research)

  In-silico drug discovery methods can help in identifying drug targets via bioinformatics tools. In addition, the methods can also be used to analyse the target structures for possible binding active sites. The use of computational methods and computers permeates all aspects of drug discovery and drug design. The methods are facilitating the access of massive amounts of data generated and transforming the extensive complex biological data into useful knowledge for the drug discovery process. These computational tools offer the advantage of delivering new drug candidates more quickly and at a lower cost. According to the market intelligence published by BIS Research, the in-silico drug discovery market is projected to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029. The global in-silico drug discovery market is undergoing a significant change with regard to the advancements that have already taken place and are currently invading the market space. Add...

  Drug discovery is used for the identification of the lead structure, which is followed by the synthesis of its analogs, and the latter’s screening to get candidate molecules for drug development. The objective of the drug discovery process is to search for new drug molecules that can bind to a specific target. Further, in the traditional drug discovery process, identifying the suitable drug target is the first and foremost task. The different steps associated with the in-silico drug discovery process include target identification, target validation, lead identification, lead optimization, pre-clinical studies, and clinical trials. The market for in-silico drug discovery is focused on software, services, and artificial intelligence. Advanced software and informatics deliver far more insight than traditional methods, with a resolution significantly higher than ever before. According to the market study published by BIS Research, the in-silico drug discovery market was estimate...